4512.T

Wakamoto Pharmaceutical Co.,Ltd.
TokyoJPYEQUITY Healthcare DELAYED
Last price
301.00
▲ 4.00 (1.35%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
300.00
Prev close
297.00
Day high
307.00
Day low
295.00
Volume
63.70K
Market cap
$10.45B
P/E (TTM)
46.09
52W range
240.00 – 380.00

Day trading desk

Current session · delayed
Gap from prior close
+1.01%
Prior close 297.00
VWAP
302.74
-0.58% from price
Relative volume
1.79×
Unusually busy
Session range
4.07%
295.00 – 307.00
Position in range
50%
Mid range
ATR (14D)
8.57
2.85% of price
Prior day high
297.00
PDH
Prior day low
283.00
PDL
Bid / ask spread
Quote not published
Session volume
93.00K
Avg 51.88K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+10.66% +12.0%
1M
+10.66% +6.9%
3M
+8.27% +5.2%
6M
-3.83% -14.9%
YTD
+5.24% -7.0%
1Y
-1.63% -21.6%
3Y
+28.63% -45.5%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 4512.T open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
15.27M
Total on file

Fundamentals

TTM · reported
Market cap$10.45B
Enterprise value$10.12B
Revenue (TTM)$9.43B
Gross profit$5.08B
EBITDA$508.00M
Net income$-222.00M
EPS (TTM)$6.53
Free cash flow$-241.00M
Total cash$1.87B
Total debt$1.66B
Book value / share$347.83
Shares outstanding34.71M
Float16.54M
Short % of float
Dividend yield1.18%
Beta (5Y)0.45

Valuation & profitability ratios

Account required
Trailing P/E46.09
Forward P/E
PEG ratio
Price / sales
Price / book0.87
EV / revenue1.07
EV / EBITDA19.92
Gross margin53.86%
Operating margin-5.83%
Profit margin-2.35%
Return on equity-1.83%
Return on assets-1.84%
Debt / equity13.69
Current ratio4.30
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2026202520242023YoY
Total revenue $9.91B$7.79B$7.74B$8.66B +27.2%
Operating revenue $9.91B$7.79B$7.74B$8.66B +27.2%
Cost of revenue $5.18B$4.17B$4.14B$4.55B +24.2%
Gross profit $4.73B$3.62B$3.60B$4.11B +30.6%
Total operating expense $4.47B$4.08B$3.80B$3.97B +9.7%
Operating income $255.54M-$457.80M-$195.51M$141.47M +155.8%
Net interest income $691.00K$549.00K-$502.00K-$550.00K +25.9%
Pre-tax income $256.40M$7.46M$158.85M$211.57M +3,338.8%
Tax provision $29.18M-$56.98M$49.90M$73.32M +151.2%
Net income $227.22M$64.44M$108.96M$138.26M +252.6%
Net income to common $227.22M$64.44M$108.96M$138.26M +252.6%
Basic EPS 6.541.853.133.98 +253.5%
Diluted EPS 6.541.853.133.98 +253.5%
EBIT $258.29M$8.34M$159.38M$212.15M +2,997.8%
EBITDA $701.22M$438.68M$570.97M$657.90M +59.8%
Basic shares 34.71M34.71M34.71M34.71M -0.0%
Diluted shares 34.71M34.71M34.71M34.71M -0.0%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 0.19
Dec 2025 10.05
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders43.88%
Held by institutions17.46%
Institutions holding4
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
277.90
+8.31% from price
SMA 20
273.10
+10.22% from price
SMA 50
269.80
+11.56% from price
SMA 100
294.83
+2.09% from price
SMA 200
300.27
+0.24% from price
EMA 12
280.45
+7.33% from price
EMA 26
275.81
+9.13% from price
EMA 50
277.33
+8.54% from price
RSI (14)
73.1
Overbought
MACD (12,26,9)
4.63
Hist 3.55
ATR (14)
8.57
2.85% of price
Realised vol 30D
29.8%
Annualised
Bollinger upper
293.22
20, 2σ
Bollinger lower
252.98
20, 2σ
50 / 200 cross
Death
269.80 vs 300.27
Trend bias
Above 200
+0.24%

Options chain

Account required
ExpirySpot 301.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.11
Less volatile than market
Correlation to SPY
-0.05
Largely independent
Realised vol 30D
29.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-33.5%
Peak to trough
Max drawdown 5Y
-47.8%
Peak to trough
ATR 14
8.57
2.85% of price
Beta (reported)
0.45
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$3.50 / yr
Forward yield1.18%
5-year avg yield1.14%
Payout ratio53.52%
Ex-dividend dateMar 30, 2027
Next pay date
Last split
Split date

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.